Parecoxib reduced ventilation induced lung injury in acute respiratory distress syndrome
Abstract Background Cyclooxygenase-2 (COX-2) contributes to ventilation induced lung injury (VILI) and acute respiratory distress syndrome (ARDS). The objective of present study was to observe the therapeutic effect of parecoxib on VILI in ARDS. Methods In this parallel controlled study performed at...
Main Authors: | Fan-you Meng, Wei Gao, Ying-nan Ju |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-03-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40360-017-0131-z |
Similar Items
-
Modified lung ultrasound score predicts ventilation requirements in neonatal respiratory distress syndrome
by: Piotr Szymański, et al.
Published: (2021-01-01) -
Strategies to prevent ventilator-associated lung injury in critically Ill patients
by: Alex Joseph, et al.
Published: (2018-01-01) -
Effect of parecoxib on remifentanil induced postoperative shivering
by: Ashraf Abd Elmawgood, et al.
Published: (2014-10-01) -
Pathophysiology and Clinical Meaning of Ventilation-Perfusion Mismatch in the Acute Respiratory Distress Syndrome
by: Douglas Slobod, et al.
Published: (2022-12-01) -
Elastic power but not driving power is the key promoter of ventilator-induced lung injury in experimental acute respiratory distress syndrome
by: Patricia R. M. Rocco, et al.
Published: (2020-06-01)